Anlotinib exerts an anti-T-cell acute lymphoblastic leukemia effect in vitro and in vivo.
Despite some progress having been made regarding the treatment of T-cell acute lymphoblastic leukemia (T-ALL), the prognosis of T-ALL, particularly adult T-ALL, is still poor. Identifying no...